Cerecor Inc



$2.60Share Price
$56 MMarket Cap
51.2%EBIT / EV
35.1%FCF / EV
33156.0%Cash ROIC
0.0%3yr Avg Revenue Growth
5.82Current Ratio
star logo

Business Model Diligence

We do not yet have Business Model Diligence for this stock.

Statistical Diligence

check mark The EBIT / Enterprise Value of 51.2% ranks as Suspicious.
check mark The Free Cash Flow / Enterprise Value of 35.1% ranks as Suspicious.
check mark The Return on Invested Capital Value of 48448.1% ranks as Suspicious.
check mark The Cash Return on Capital Value of 33156.0% ranks as Suspicious.
x mark The 3 Year Average Revenue Growth Value of 0.0% ranks as Below Average.
check mark Near-term Financial Health appears to be Very Good. The Current Ratio is 5.82.

Company Description

Cerecor, Inc. is a clinical stage biopharmaceutical company focuses in medical development. It involves in the discovery, manufacture and commercialization of prescription for neurological and psychiatric disorders. It products include CERC-301, CERC-501, CERC-611, and CERC-406. The company was founded by Blake M. Paterson, Isaac Blech, Barbara S. Slusher and Solomon H. Snyder on January 31, 2011 and is headquartered in Baltimore, MD.


You must have a MagicDiligence Membership to view the Calculations for this stock. If you are already a member, you need to log in first.
Tracking Portfolios
blue wand Magic Recipe 29.36%
purple wand Deep Value 24.71%
orange wand Quality Growth 44.22%
green wand Green Team 6.14%
red dot Red Rating 5.76%
yellow dot Yellow Rating 14.17%
green dot Green Rating 14.95%
New Spell Stocks
blue wand Vector Group Ltd. (VGR)
purple wand New Stocks Added!